Position in VTRS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,866,743
+$2,253,693 QoQ
Shares Held
306,470
+58.5% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#169
of 1,016 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026New York Life Investment Management LLC holds $14,583,179 across 6 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (33.4% of the industry book) .
All Filings in VTRS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,866,743 | 306,470 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,613,050 | 193,416 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,614,163 | 209,973 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,725,994 | 275,353 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,521,126 | 282,321 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,390,185 | 159,608 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,993,867 | 160,150 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,844,770 | 158,895 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,931,077 | 181,663 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,958,923 | 164,064 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,844,608 | 170,324 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,734,945 | 175,958 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,740,980 | 174,447 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,695,726 | 176,271 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,953,860 | 175,549 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,500,832 | 176,154 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,830,208 | 174,805 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||